Moderna ramps up EU COVID jab capacity via Lonza dealCapacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, Share XModerna ramps up EU COVID jab capacity via Lonza dealhttps://pharmaphorum.com/news/moderna-ramps-up-eu-covid-jab-capacity-via-lonza-deal/
FDA pens stinging report on Emergent COVID vaccine plantEmergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which Share XFDA pens stinging report on Emergent COVID vaccine planthttps://pharmaphorum.com/news/fda-pens-stinging-report-on-emergent-covid-vaccine-plant/
COVID-19 underscores need to boost pharma manufacturing in emerging marketsFor the past year, life science companies around the world worked at breakneck speed to develop and manufacture Share XCOVID-19 underscores need to boost pharma manufacturing in emerging marketshttps://pharmaphorum.com/views-and-analysis/covid-underscores-need-to-boost-pharma-manufacturing-in-emerging-markets/
Bomb scare sparks evacuation of plant making AZ COVID-19 vaccineA plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today Share XBomb scare sparks evacuation of plant making AZ COVID-19 vaccinehttps://pharmaphorum.com/news/bomb-scare-sparks-evacuation-of-plant-making-az-covid-19-vaccine/
Why cell therapy manufacture is a team sportLouis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that Share XWhy cell therapy manufacture is a team sporthttps://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/
Pfizer cut vaccine production targets because of raw material shortage – reportsPfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its Share XPfizer cut vaccine production targets because of raw material shortage – reportshttps://pharmaphorum.com/news/pfizer-cut-vaccine-production-targets-because-of-raw-material-shortage-reports/
BioNTech, InstaDeep plan joint lab for AI researchBioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to Share XBioNTech, InstaDeep plan joint lab for AI researchhttps://pharmaphorum.com/news/biontech-instadeep-plan-joint-lab-for-ai-research/
Could an FDA inspection scupper CVR deadline for BMS’ liso-cel?Bristol-Myers Squibb posted a solid set of financial results for the third quarter, but shares slid on investor Share XCould an FDA inspection scupper CVR deadline for BMS’ liso-cel?https://pharmaphorum.com/news/could-an-fda-inspection-scupper-cvr-deadline-for-bms-liso-cel/
Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedPfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at Share XPfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedhttps://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/
